Zinc is an essential component of biomembranes and is necessary for ma
intenance of membrane structure and function. There is evidence that z
inc can provide antiatherogenic properties by preventing metabolic phy
siologic derangements of the vascular endothelium. Because of its anti
oxidant and membrane-stabilizing properties, zinc appears to be crucia
l for the protection against cell-destabilizing agents such as polyuns
aturated lipids and inflammatory cytokines. Zinc also may be antiather
ogenic by interfering with signaling pathways involved in apoptosis. M
ost importantly, we have evidence that zinc can protect against inflam
matory cytokine-mediated activation of oxidative stress-responsive tra
nscription factors, such as nuclear factor kappa B and AP-1. It is ver
y likely that certain lipids and zinc deficiency may potentiate the cy
tokine-mediated inflammatory response and endothelial cell dysfunction
in atherosclerosis. Thus, the antiatherogenic role of zinc appears to
be in its ability to inhibit oxidative stress-responsive factors invo
lved in disruption of endothelial integrity and atherosclerosis. We di
scuss antiatherogenic properties of zinc with a focus on endothelial c
ell metabolism.